Compare · CELZ vs SYF
CELZ vs SYF
Side-by-side comparison of Creative Medical Technology Holdings Inc. (CELZ) and Synchrony Financial (SYF): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CELZ and SYF operate in Finance: Consumer Services (Finance), so they compete in similar markets.
- SYF is the larger of the two at $27.55B, about 4436.5x CELZ ($6.2M).
- SYF has been more active in the news (16 items in the past 4 weeks vs 2 for CELZ).
- SYF has more recent analyst coverage (25 ratings vs 1 for CELZ).
Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem for the treatment of erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine for the treatment of chronic lower back pain; Amniostem for the treatment of strokes, radiation, toxicity, and glioma; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. was incorporated in 1998 and is based in Phoenix, Arizona.
Synchrony Financial
Synchrony Financial operates as a consumer financial services company in the United States. It provides a range of specialized financing programs and consumer banking products to digital, retail, home, auto, travel, health, and pet industries. The company also offers private label credit cards, dual cards, general purpose co-branded credit cards, and small and medium-sized business credit products; and promotional financing for consumer purchases, such as private label credit cards, dual cards, and installment loans. In addition, it provides promotional financing to consumers for health, veterinary and personal care procedures, and services and products, such as dental, vision, audiology, and cosmetic; debt cancellation products; and deposit products, including certificates of deposit, individual retirement accounts, money market accounts, and savings accounts to retail and commercial customers, as well as accepts deposits through third-party securities brokerage firms. The company offers its credit products through programs established with a group of national and regional retailers, local merchants, manufacturers, buying groups, industry associations, and healthcare service providers; and deposit products through various channels, such as digital and print. Synchrony Financial was incorporated in 2003 and is headquartered in Stamford, Connecticut.
Latest CELZ
- President & CEO Warbington Timothy was granted 1,000,000 shares (SEC Form 4)
- Creative Medical Technology Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
- Creative Medical Technology Holdings, Inc. Expands Ultrasome™ Intellectual Property Portfolio with New U.S. Provisional Patent Filing
- Creative Medical Technology Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Creative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared ADAPT Trial, Including Opioid Cohort, Advancing CELZ-201 / Olastrocel Toward RMAT Evaluation and Phase 3 Planning
- SEC Form 10-Q filed by Creative Medical Technology Holdings Inc.
- Creative Medical Technology Holdings, Inc. Receives Notice of Allowance for New U.S. Patent Covering Exosome-Based Immunotherapy for Type 1 Diabetes, Deepening IP Protection Across Its MyeloCelz™, CELZ-101 and CELZ-201 Diabetes Platforms
- SEC Form 424B3 filed by Creative Medical Technology Holdings Inc.
- SEC Form EFFECT filed by Creative Medical Technology Holdings Inc.
- SEC Form S-3 filed by Creative Medical Technology Holdings Inc.
Latest SYF
- Weave and CareCredit Go Live with Integration That Places Patient Financing Inside the Front-Office Workflow
- BMO Capital Markets initiated coverage on Synchrony Financial with a new price target
- Director Coviello Arthur W Jr was granted 846 shares, increasing direct ownership by 3% to 27,012 units (SEC Form 4)
- Director Alves Paget Leonard was granted 846 shares, increasing direct ownership by 2% to 53,380 units (SEC Form 4)
- Director Colao Daniel O was granted 846 shares, increasing direct ownership by 15% to 6,528 units (SEC Form 4)
- Director Aguirre Fernando was granted 846 shares, increasing direct ownership by 3% to 31,119 units (SEC Form 4)
- Director Zane Ellen M was granted 846 shares, increasing direct ownership by 3% to 33,087 units (SEC Form 4)
- Director Naylor Jeffrey G was granted 1,287 shares, increasing direct ownership by 2% to 66,904 units (SEC Form 4)
- Director Richie Laurel was granted 846 shares, increasing direct ownership by 2% to 52,670 units (SEC Form 4)
- Director Chytil Kamila K was granted 846 shares, increasing direct ownership by 5% to 18,775 units (SEC Form 4)